Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia
- PMID: 27843119
- DOI: 10.1016/j.prrv.2016.08.013
Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia
Abstract
Bronchopulmonary dysplasia (BPD) is a frequent complication occurring in extremely preterm infants. Despite recent advances in newborn medicine, the incidence of BPD does not appear to have changed markedly, and specific treatments and prevention strategies are still lacking. Nutrition plays an important role in normal lung development and maturation. Malnutrition may delay somatic growth and new alveoli development, thus aggravating pulmonary injury involved in the pathogenesis of BPD. However, few nutrients have been investigated for their potential to mitigate the pathogenesis of BPD. In this article, we reviewed the recent progress in research on potential nutrients useful for the prevention or treatment of BPD, including glutamine, cysteine and N-acetylcysteine, L-arginine and L-citrulline, long chain polyunsaturated fatty acids (LCPUFAs), inositol, selenium, and some antioxidant vitamins including vitamin A. Current evidence shows that vitamin A and LCPUFA can prevent BPD, and that L-citrulline might provide a new method to treat chronic pulmonary hypertension associated with BPD in premature infants. The effects of other nutrients on BPD prevention need to be further studied.
Keywords: Bronchopulmonary dysplasia; L-citrulline; long chain polyunsaturated fatty acids; nutrient; vitamin A.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Pharmacokinetics of L-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.Paediatr Drugs. 2023 Jan;25(1):87-96. doi: 10.1007/s40272-022-00542-x. Epub 2022 Oct 31. Paediatr Drugs. 2023. PMID: 36316628 Free PMC article.
-
Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia.J Nutr. 2001 Mar;131(3):942S-946S. doi: 10.1093/jn/131.3.942S. J Nutr. 2001. PMID: 11238791 Review.
-
Antioxidants: Role the in prevention and treatment of bronchopulmonary dysplasia.Paediatr Respir Rev. 2022 Jun;42:53-58. doi: 10.1016/j.prrv.2022.01.003. Epub 2022 Jan 25. Paediatr Respir Rev. 2022. PMID: 35177319 Review.
-
Strategies for preventing bronchopulmonary dysplasia.Curr Opin Pediatr. 2005 Apr;17(2):174-80. doi: 10.1097/01.mop.0000158732.64293.1c. Curr Opin Pediatr. 2005. PMID: 15800407 Review.
-
L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats.Pediatr Res. 2010 Dec;68(6):519-25. doi: 10.1203/PDR.0b013e3181f90278. Pediatr Res. 2010. PMID: 20805789 Free PMC article.
Cited by
-
PGC-1α activity and mitochondrial dysfunction in preterm infants.Front Physiol. 2022 Sep 26;13:997619. doi: 10.3389/fphys.2022.997619. eCollection 2022. Front Physiol. 2022. PMID: 36225305 Free PMC article. Review.
-
Present and Future of Bronchopulmonary Dysplasia.J Clin Med. 2020 May 20;9(5):1539. doi: 10.3390/jcm9051539. J Clin Med. 2020. PMID: 32443685 Free PMC article. Review.
-
New-generation intravenous fat emulsions and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.J Perinatol. 2020 Nov;40(11):1585-1596. doi: 10.1038/s41372-020-0716-z. Epub 2020 Jul 7. J Perinatol. 2020. PMID: 32636446
-
Tracheostomy in Severe Bronchopulmonary Dysplasia-How to Decide in the Absence of Evidence.Biomedicines. 2023 Sep 19;11(9):2572. doi: 10.3390/biomedicines11092572. Biomedicines. 2023. PMID: 37761012 Free PMC article. Review.
-
Targeting the lung endothelial niche to promote angiogenesis and regeneration: A review of applications.Front Mol Biosci. 2022 Dec 19;9:1093369. doi: 10.3389/fmolb.2022.1093369. eCollection 2022. Front Mol Biosci. 2022. PMID: 36601582 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical